3 hours agoIntestine cancer medicine, which is giving scientists hope
Periskopi(4 years ago)
(4 years ago)A new drug for balretric cancer (bowel cancer) has surprised scientists with its effectiveness against the extremely dangerous disease, since the drug healed every member of a test team, writes the Daily Mail, records Periscope. Dostarlimb, a monochlonal antibody drug that has already been approved for treatment of endometric cancer (the womb) in the Kingdom. [...]
A new drug for balretric cancer (bowel cancer) has surprised scientists with its effectiveness against the extremely dangerous disease, since the drug healed every member of a test team, writes the Daily Mail, records Periscope.
Dostarlibe, a monochlonal antibody drug that has already been approved for treatment of endometric cancer in the United Kingdom, exceeded expectations at a Cancer Cancer Center in New York.
A year after the surveillance ended, the cancer of all 18 participants had gone to reassession, with doctors unable to find signs of cancer in their bodies.
Dr. Luis Diaz, one of the research leaders, said: “I believe this is the first time that has happened in the history of cancer. It's very exciting. I think this is a big step for patients”.
Diaz, who is a member of the White House's National Cancer Supervisor Board, told the New York Times that the discovery is “The iceberg's”.
Dostarlibe can be used in patients with genetic specifics known as MMRd and MSI.
In Great Britain, a dose of medicine costs 5,887 pounds.
